Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 76.9 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 32.3 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 26.9 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 11.1 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 223.8 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 212.1 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control
Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 114.9 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control